Partnership for Cures
Driving More Treatments to More Patients More Quickly
Programs and results
What we aim to solve
Cures Within Reachs mission is to leverage the speed, safety and cost-effectiveness of repurposing, testing approved therapies for unsolved diseases: driving more treatments to more patients more quickly.
Our programs
What are the organization's current programs, how do they measure success, and who do the programs serve?
Proof of Concept Clinical Trials
These studies test new hypotheses for disease treatment and require initial funding of $50,000-$150,000. They include pilot clinical trials in unsolved disease testing drugs, devices, nutraceuticals and diagnostics already approved for human use.
Where we work
Awards
Fellowship in Social Entrepreneurship 2009
Ashoka
External reviews
Videos
Our results
How does this organization measure their results? It's a hard question but an important one.
Estimated number of funding dollars secured for the sector
This metric is no longer tracked.Totals By Year
Related Program
Proof of Concept Clinical Trials
Type of Metric
Outcome - describing the effects on people or issues
Direction of Success
Holding steady
Context Notes
In 2023, $16 million in new funding was raised by our researchers for ongoing trials or next phase trials.
Number of demonstration project or pilot sites
This metric is no longer tracked.Totals By Year
Population(s) Served
People with diseases and illnesses
Related Program
Proof of Concept Clinical Trials
Type of Metric
Output - describing our activities and reach
Direction of Success
Holding steady
Context Notes
In 2023, we selected 13 new trials for funding.
Number of volunteers
This metric is no longer tracked.Totals By Year
Population(s) Served
People with diseases and illnesses
Related Program
Proof of Concept Clinical Trials
Type of Metric
Input - describing resources we use
Direction of Success
Increasing
Context Notes
In 2023, more than 90 volunteer Grant Review Committee members, representing research, clinicians, industry and the patient / community voice, helped us plus our volunteer Board leadership.
Goals & Strategy
Learn about the organization's key goals, strategies, capabilities, and progress.
Charting impact
Four powerful questions that require reflection about what really matters - results.
What is the organization aiming to accomplish?
Our goal: finding and funding proof-of-concept clinical trials of drugs, diagnostics, devices and nutraceuticals that, once successful, de-risk and catalyze follow-on funding for the larger, confirmatory trials, building the clinical evidence required for regulatory approval or to support off-label use by patients everywhere.
What are the organization's key strategies for making this happen?
Cures Within Reachs Repurposing Communities: Disease Areas, Geographies, Population Groups
In 2019, Cures Within Reach launched Repurposing Communities to provide strategic alignment among our many stakeholder groups within disease-specific andgeographic areas of interests. Engagement by all our stakeholder groups can be enhanced within the specific community as well as through CWR central organization, including patient groups and disease associations, universities and research institutions, healthcare industry and service providers, philanthropy, and government / others.
In 2021, we expanded into population groups, adding Pediatrics, Veterans & Military, and Minority & Underserved (DEI) areas of interests.
Our Disease-Specific Communities
Neurology (including mental health, neurodegenerative and pain)
Oncology
Rare diseases
OurGeographic-Specific Communities
Chicago
The Mid-Atlantic (includes Washington DC, VA, MD, DE and parts of PA)
Low and Lower-Middle Income Countries - LMICs (per the World Bank)
Our Patient Population Communities
Pediatrics
Veterans and Active Military
Underrepresented Patients and Researchers - Diversity, Equity & Inclusion (includes health disparities)
What are the organization's capabilities for doing this?
Philanthropy Focused on Speed-to-Impact
Together with our donor partners, Cures Within Reach is de-risking new treatment options for patients, supporting researchers who have the clinical repurposing ideas to quickly reach patients everywhere. Our donor partners choose their desired level of engagement in the design, search and selection process. Cures Within Reach's experienced team customizes the approach with each donor. Grants starting at $60,000 and up to $250,000 can support a small, proof-of-concept human clinical trial or an expansion of an ongoing trial.
Value Proposition:
An expert team providing bespoke services designed to meet your needs
Technical expertise in finding, selecting, de-risking and managing Cures Within Reach's funded clinical trials
Access to Cures Within Reach's vast global research network
An efficient, proven RFP process, including external Grant Review Committee members representing research, industry, clinicians and the patient/community voice that support selection and strengthen trial protocols
Project and financial progress reports both during and after the clinical trials
Donor-advised funding can support a specific disease, geography, patient population or other theme of donors choosing.
What have they accomplished so far and what's next?
For nearly 20 years, Cures Within Reach has found and funded over 130 repurposing research projects in over 80 institutions in 70 different diseases. This has resulted in supporting research that found 21 new treatment options - repurposed therapies - for children with deadly diseases ALPS and FD, adults with multiple sclerosis, lung cancer, blood cancer, myelodysplastic syndrome and prostate cancer, adult and children with type 1 and type 2 diabetes, tuberculosis, nerve trauma and more. Our $9 million in funding has helped to catalyze more than $99 million in follow-on funding - a strong leverage metric.
Financials
Unlock nonprofit financial insights that will help you make more informed decisions. Try our monthly plan today.
- Analyze a variety of pre-calculated financial metrics
- Access beautifully interactive analysis and comparison tools
- Compare nonprofit financials to similar organizations
Want to see how you can enhance your nonprofit research and unlock more insights?
Learn more
about GuideStar Pro.
Operations
The people, governance practices, and partners that make the organization tick.
Connect with nonprofit leaders
SubscribeBuild relationships with key people who manage and lead nonprofit organizations with GuideStar Pro. Try a low commitment monthly plan today.
- Analyze a variety of pre-calculated financial metrics
- Access beautifully interactive analysis and comparison tools
- Compare nonprofit financials to similar organizations
Want to see how you can enhance your nonprofit research and unlock more insights? Learn More about GuideStar Pro.
Connect with nonprofit leaders
SubscribeBuild relationships with key people who manage and lead nonprofit organizations with GuideStar Pro. Try a low commitment monthly plan today.
- Analyze a variety of pre-calculated financial metrics
- Access beautifully interactive analysis and comparison tools
- Compare nonprofit financials to similar organizations
Want to see how you can enhance your nonprofit research and unlock more insights? Learn More about GuideStar Pro.
Partnership for Cures
Board of directorsas of 01/31/2024
Margaret Christie
Margaret Christie
Golan Christie Taglia, LLC
Steve Braun
Northwestern Mutual Financial Network
Matt Rich
PWC
David Styler
Horizon Therapeutics
Lucy Mancini-Newell
Rob Metz
Armour Life Sciences
Nancy Sullivan
Illinois Ventures
Kristina Allikments
Takeda Pharma
Nicholas Manusos
Organizational demographics
Who works and leads organizations that serve our diverse communities? Candid partnered with CHANGE Philanthropy on this demographic section.
Leadership
The organization's leader identifies as:
Race & ethnicity
No data
Gender identity
Transgender Identity
Sexual orientation
No data